摘要 |
Compounds of formula (I) : <CHEM> in which: R<1> is hydrogen or alkyl; R<2> is alkylene; R<3> is hydrogen, alkyl, alkoxy, alkylthio, halogen, nitro group, amino group, monoalkylamino, dialkylamino, aryl, or aralkyl; X is aryl, or aromatic heterocyclic; Y is oxygen, sulfur or a group of formula >N-R<4>, in which R<4> is hydrogen, alkyl or acyl; and Z is a group of formula (Za), (Zb), (Zc) or (Zd) : <CHEM> <CHEM> and salts thereof can be used to treat or prevent are included those arising from hyperlipidemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistant non-IGT (NGT), non-diagnostic glucose tolerance, insulin resistance, diabetic complications, fatty liver, polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM); in addition the compounds of the present invention have aldose reductase inhibitory activity. |